Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
JAC-Antimicrobial Resistance is Scopus-indexed (Q2, CiteScore 5.3), WoS ESCI, DOAJ. Published by Oxford University Press.
Checked against the index lists dated .
ISSN 2632-1823Verify ISSN ↗
Publisher: Oxford University Press
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 110 / 361 | 69th | Q2 |
| Microbiology (medical) | 56 / 147 | 62nd | Q2 |
| Immunology and Allergy | 102 / 234 | 56th | Q2 |
| Microbiology | 91 / 194 | 53rd | Q2 |
| Immunology | 116 / 243 | 52nd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q2, CiteScore 5.3.
JAC-Antimicrobial Resistance is Q2 in Infectious Diseases (rank 110 of 361), Q2 in Microbiology (medical) (rank 56 of 147) and Q2 in Immunology and Allergy (rank 102 of 234), by CiteScore 2025. It is ranked in 5 subject areas in all.
JAC-Antimicrobial Resistance is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.3, which places it in quartile Q2 at the 69th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.057, quartile Q1, with an H-index of 36.
The publisher lists an article processing charge of about US$2,609 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
JAC-Antimicrobial Resistance is published by Oxford University Press. Its ISSN is 2632-1823.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
JAC-Antimicrobial Resistance has an h-index of 48 and a 2-year mean of 2.45 citations per paper (OpenAlex). Its Scopus CiteScore is 5.3, quartile Q2. On 2-year citations it ranks #133 of 354 Scopus journals in Infectious Diseases.
JAC-Antimicrobial Resistance published 462 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from United Kingdom (22.7%), United States (11.1%) and Italy (6.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.